We cannot ascertain whether this is due to chance based solely on the mathematical model; however, data in the literature regarding the role of metalloproteinases in carcinogenesis and the HER2 pathway in breast cancer lead us to believe in the potential of these findings as a foundation for further research, rather than as definitive clinical conclusions. This evidence concerns the gene ERBB2 and breast carcinoma.